- Home
- CTMX vs NFGC Comparison
CTMX vs NFGC Comparison
Compare CTMX & NFGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- NFGC
- Stock Information
- Founded
- CTMX 2008
- NFGC 2016
- Country
- CTMX United States
- NFGC Canada
- Employees
- CTMX N/A
- NFGC N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- NFGC Precious Metals
- Sector
- CTMX Health Care
- NFGC Basic Materials
- Exchange
- CTMX Nasdaq
- NFGC Nasdaq
- Market Cap
- CTMX 596.2M
- NFGC 588.1M
- IPO Year
- CTMX 2015
- NFGC N/A
- Fundamental
- Price
- CTMX $3.64
- NFGC $2.18
- Analyst Decision
- CTMX Strong Buy
- NFGC Strong Buy
- Analyst Count
- CTMX 6
- NFGC 1
- Target Price
- CTMX $6.50
- NFGC $5.00
- AVG Volume (30 Days)
- CTMX 3.9M
- NFGC 1.4M
- Earning Date
- CTMX 11-06-2025
- NFGC 11-07-2025
- Dividend Yield
- CTMX N/A
- NFGC N/A
- EPS Growth
- CTMX 50.22
- NFGC N/A
- EPS
- CTMX 0.24
- NFGC N/A
- Revenue
- CTMX $113,631,000.00
- NFGC N/A
- Revenue This Year
- CTMX N/A
- NFGC N/A
- Revenue Next Year
- CTMX N/A
- NFGC N/A
- P/E Ratio
- CTMX $15.28
- NFGC N/A
- Revenue Growth
- CTMX N/A
- NFGC N/A
- 52 Week Low
- CTMX $0.40
- NFGC $0.93
- 52 Week High
- CTMX $4.62
- NFGC $2.82
- Technical
- Relative Strength Index (RSI)
- CTMX 50.34
- NFGC 55.04
- Support Level
- CTMX $3.35
- NFGC $1.95
- Resistance Level
- CTMX $4.45
- NFGC $2.20
- Average True Range (ATR)
- CTMX 0.37
- NFGC 0.13
- MACD
- CTMX -0.06
- NFGC 0.02
- Stochastic Oscillator
- CTMX 30.00
- NFGC 95.64
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About NFGC New Found Gold Corp
New Found Gold Corp is a mineral exploration company engaged in the acquisition, exploration and evaluation of resource properties with a focus on gold properties located in the Provinces of Newfoundland and Labrador and Ontario, Canada. The Company's exploration is focused on discovering and delineating gold resources. The Company has one material property: the Queensway Project located in Newfoundland, Canada (the Queensway Project).